Cohance Lifesciences Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Sep-24	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26
	258	307	402	549	556	545	619	422
	14	16	11	14	16	6	−2	12
	172	213	361	493	487	505	581	477
	47	67	70	178	192	197	139	159
	5	−11	64	−30	−50	−38	75	−38
	52	63	89	133	127	119	129	133
	2	3	6	10	9	9	9	7
	17	20	27	45	44	47	51	50
	50	71	105	156	167	172	177	168
	118	133	84	118	137	97	80	13
	101	113	57	73	93	50	29	−36
	—	—	—	−8	—	−5	−17	—
	100	110	52	63	84	41	20	−43
	18	26	13	16	17	12	12	2
	82	83	39	46	66	29	8	−45
Financial ratios
	45.84%	43.43%	20.93%	21.50%	24.58%	17.75%	12.97%	3.18%
	31.81%	27.12%	9.63%	8.45%	11.95%	5.33%	1.34%	-10.70%
	3.23	3.26	1.65	1.28	1.94	0.96	0.51	-0.63

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.